Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection ( ht. About Sirion Therapeutics Inc. ...)

(Date:10/13/2008)...ave Higher Sensitivity and Specificity, than Othe...he preferred test in all phases of...- AT First Diagnostic LLC an,emerging...st kits, today,announced that a recent evaluation ...earch of the FirstVue(TM) HBSAG Test, was released...

(Date:10/13/2008)...tiple Cancer Populations Facilitates ...Oct. 13 /- Rubicon Genomics, Inc. tod...mplify DNA samples for The,Cancer Atlas Genome Pro...nd standardize total genomic,DNA from 3,000 tissue...on,GenomePlex(TM) Whole Genome Amplification techn...

(Date:10/12/2008)...in Combination with Chemotherapy, FREMONT, Calif....c., a,development-stage pharmaceutical company dis...Ai)-based therapeutics, today announced that the,j...cy of siRNA targeting,its proprietary target gene ...edition dated October 1, 2008. The paper, entitled...

(Date:10/12/2008)...t. 12 /- Boston,Scientific ...from an analysis,of nearly 7,500 patients from its...ed to confirm the performance of the TAXUS(R) Expr...in real-world practice. The,two-year pooled ARRIVE...,restenosis in patients with diabetes as effective...

Breaking Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2 Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3 Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4 Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2 Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4 TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2 TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3 TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4 TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5 Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 18813 1 Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 18813 2 Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 18813 3 Previously unseen switch regulates breast cancer response to estrogen 18812 1 Previously unseen switch regulates breast cancer response to estrogen 18812 2 Phase III pivotal results presented of VYVANSE to treat ADHD in adults 18811 1 Phase III pivotal results presented of VYVANSE to treat ADHD in adults 18811 2 Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life Including Pregnancy 18807 1 Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life Including Pregnancy 18807 2 Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life Including Pregnancy 18807 3

[1] Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests [0] Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project [0] Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy [0] TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program

...ically meaningful pain relief within 5,minutes of ... June 2007 - Archimedes Pharma Ltd,("Archimedes"),...y,presented new clinical data from a Phase II stud...nasal spray aimed at providing a,fast, effective a...in. Data were presented at the 10th Congress of th...

...ating zonisamide SR as a novel component in,EMPATI... 2007 /PRNewswire-FirstCall/ -- Orexigen(TM),Thera...d on the,treatment of central nervous system disor...nced results from a Phase I trial evaluating,safet...sustained-release (SR) formulation of zonisamide. ...

Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2 Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3 OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2 OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3 OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4

Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation

(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...

(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...

(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...

(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....

Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2 Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2 Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3 Health News:National Psoriasis Foundation Releases 2008 Study Results 2 Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2

[0] Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives![0] National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography [0] National Psoriasis Foundation Releases 2008 Study Results [0] MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource

... the womb! Mothers can prevent the occurrence of c...e course of life //just by having a nutritious die...vegetables like cabbage and broccoli. A new study ...titute at Oregon State University, done with labor...

...nics were developed by scientists with a vision to... all defective genes from the gene pool. // But no...ade to order. Though it sounds absurd, ‘why should...To some parents with disabilities like deafness an...

...indicated that blood tests which were designed to ... good //as cholesterol tests , or blood pressure t... veritable risk indicator. Doctors have been mak...d which they interpreted as indicators of a heart ...

..., effectiveness and reliability of LASIK and LASEK...etween the two types of laser eye// surgery. The ...researcher, is published in the December 2006 issu...f Ophthalmology. "Although there have been many s...

Other Medicine News:Health News:Cancer Prevention Begins During Pregnancy 2 Health News:Cancer Prevention Begins During Pregnancy 3 Health News:Can Defective Babies Be Made To Order? 2 Health News:Study Compares LASIK and LASEK Eye Surgery 2

Cancer Prevention Begins During Pregnancy Can Defective Babies Be Made To Order?Blood Tests That Promise to Predict Heart Attacks Turn Out to Be a Flash in the Pan Study Compares LASIK and LASEK Eye Surgery

Gentamicin Reagent Solution (10 mg/ml) liquid

LB Agar plates with 0.1mM EDTA.

Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride.

2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride.

Medicine Products:

Gibco Gentamicin Reagent Solution (10 mg/ml) liquid LB Agar Plates EDTA-0.1 LB-BROTH, liquid, 10 g NaCl Inoculum Broth with Calcium Chloride

( ht. About Sirion Therapeutics Inc. ...)Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection,Health